4
Views
1
CrossRef citations to date
0
Altmetric
Research Article

Cefotaxime (‘Claforan’) in routine hospital use

Pages 104-112 | Received 12 Mar 1982, Published online: 11 Aug 2008

References

  • Bax R. P., Young J. P. W. Cefotaxime: United Kingdom clinical trial results in the treatment of severe infections. Curr. Med. Res. Opin. 1981; 7: 4011. Bax R. P., Young J. P. W. Cefotaxime: United Kingdom clinical trial results in the treatment of severe infections. Curr. Med. Res. Opin. 1981; 7: 401
  • Belohradsky B. H., Geiss D., Marget W., Bruch K., Kafetzis D., Peters G. Intravenous cefotaxime in children with bacterial meningitis. Lancet 1980; 1: 612. Belohradsky B. H., Geiss D., Marget W., Bruch K., Kafetzis D., Peters G. Intravenous cefotaxime in children with bacterial meningitis. Lancet 1980; 1: 61
  • Brown W. M., Fallon R. J. Cefotaxime for bacterial meningitis. Lancet 1979; 1: 12463. Brown W. M., Fallon R. J. Cefotaxime for bacterial meningitis. Lancet 1979; 1: 1246
  • Daikos G. K., Kosmidis J., Giamarellou H., Dravidis B., Stathakis C. L., Mantopoulos K. Evaluation of cefotaxime in a hospital with high antibiotic resistance rates. J. Antimicrob. Chemother. 1980; 6(Suppl. A)2554. Daikos G. K., Kosmidis J., Giamarellou H., Dravidis B., Stathakis C. L., Mantopoulos K. Evaluation of cefotaxime in a hospital with high antibiotic resistance rates. J. Antimicrob. Chemother. 1980; 6(Suppl. A)255
  • Drasar F. A., Farrell W., Howard A. J., Hince C., Leung T., Williams J. D. Activity of HR756 against Haemophilus influenzae, Bacteroides fragilis and Gram-negative rods. J. Antimicrob. Chemother. 1978; 4: 4455. Drasar F. A., Farrell W., Howard A. J., Hince C., Leung T., Williams J. D. Activity of HR756 against Haemophilus influenzae, Bacteroides fragilis and Gram-negative rods. J. Antimicrob. Chemother. 1978; 4: 445
  • Hamilton-Miller J. M. T., Brumfitt W., Reynolds A. V. Cefotaxime (HR 756) a new cephalosporin with exceptional broad spectrum activity, in vitro. J. Antimicrob. Chemother. 1978; 4: 4376. Hamilton-Miller J. M. T., Brumfitt W., Reynolds A. V. Cefotaxime (HR 756) a new cephalosporin with exceptional broad spectrum activity, in vitro. J. Antimicrob. Chemother. 1978; 4: 437
  • McKendrick M. W., Geddes A. M., Wise R., Andrews J. A. Cefotaxime – a clinical study. J. Antimicrob. Chemother. 1981; 7: 4057. McKendrick M. W., Geddes A. M., Wise R., Andrews J. A. Cefotaxime – a clinical study. J. Antimicrob. Chemother. 1981; 7: 405
  • Newsom S. W. B., Matthews J., Pearce V. R. Cefotaxime in urinary infections. J. Antimicrob. Chemother. 1980; 6(Suppl. A)1998. Newsom S. W. B., Matthews J., Pearce V. R. Cefotaxime in urinary infections. J. Antimicrob. Chemother. 1980; 6(Suppl. A)199
  • Rimmer D. (1979) Cefotaxime in the treatment of septicaemia. Proc. 19th I.C.A.A.C., Boston, Oct., 1979, 1329. Rimmer D. (1979) Cefotaxime in the treatment of septicaemia. Proc. 19th I.C.A.A.C., Boston, Oct., 1979, 132
  • Young J. P. W., Husson J. M., Bruch K., Blomer R. J., Savopoulos C. The evaluation of efficacy and safety of cefotaxime: a review of 2500 cases. J. Antimicrob. Chemother. 1980; 6(Suppl. A)29310. Young J. P. W., Husson J. M., Bruch K., Blomer R. J., Savopoulos C. The evaluation of efficacy and safety of cefotaxime: a review of 2500 cases. J. Antimicrob. Chemother. 1980; 6(Suppl. A)293

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.